SCHD’s $71.6 Billion Portfolio Delivers 20% YTD Gain
Schd’s $71.6 billion portfolio has posted a 20% year-to-date price gain alongside a 3.3% yield, underscoring the appe...
Stock index values update on scheduled times or upon data arrivals, varying by index and exchange. This piece covers the timing and implications.
22,965 articlesSchd’s $71.6 billion portfolio has posted a 20% year-to-date price gain alongside a 3.3% yield, underscoring the appe...
JEPI investors missed 13.21% gains in a strong market as an options overlay muted upside and taxes eroded income. Thi...
The Dow fell nearly 800 points after Fed Chair Powell indicated there is no rush to rescue the market, triggering bro...
A leading portfolio strategist warns that the market could enter another lost decade of real returns as valuations st...
Choosing the right pharmaceutical ETF can feel like balancing income with growth. This guide compares VanEck's PPH an...
Choosing the right global real estate ETF can boost income and diversification. This guide compares VNQI and REET, hi...
Healthcare sector ETFs offer defense and income, but not all are created equal. This article dives into how state str...
A yen-hedged approach to Japan equities outperformed the unhedged EWJ by roughly six percentage points in the first h...
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
With savings yields retreating as the Fed eases policy, two utility ETFs offer a compelling mix of income and upside....
Inflation can quietly erode fixed income’s purchasing power. This practical, straightforward guide shows you how to t...
Geopolitical tensions flare as reports detail a more aggressive Iran posture. Bitcoin and other risk assets react as ...